Loading...

Nathaniel Fleming, MD, MS

Title(s)Resident, Neurology
SchoolSchool of Medicine
Phone415-353-2273
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Fleming NH, Shaub AR, Bailey E, Swetter SM. Outcomes of surgical re-excision versus observation of severely dysplastic nevi: A single-institution, retrospective cohort study. J Am Acad Dermatol. 2019 Jul 17. PMID: 31325549.
      View in: PubMed
    2. Kim CC, Berry EG, Marchetti MA, Swetter SM, Lim G, Grossman D, Curiel-Lewandrowski C, Chu EY, Ming ME, Zhu K, Brahmbhatt M, Balakrishnan V, Davis MJ, Wolner Z, Fleming N, Ferris LK, Nguyen J, Trofymenko O, Liu Y, Chen SC. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins. JAMA Dermatol. 2018 12 01; 154(12):1401-1408. PMID: 30304348.
      View in: PubMed
    3. Fleming NH, Grade MM, Bendavid E. Impact of primary care provider density on detection and diagnosis of cutaneous melanoma. PLoS One. 2018; 13(7):e0200097. PMID: 30005065.
      View in: PubMed
    4. Fleming NH, Egbert BM, Kim J, Swetter SM. Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi. JAMA Dermatol. 2016 12 01; 152(12):1327-1334. PMID: 27542070.
      View in: PubMed
    5. Rendleman J, Vogelsang M, Bapodra A, Adaniel C, Silva I, Moogk D, Martinez CN, Fleming N, Shields J, Shapiro R, Berman R, Pavlick A, Polsky D, Shao Y, Osman I, Krogsgaard M, Kirchhoff T. Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma. J Med Genet. 2015 Apr; 52(4):231-9. PMID: 25604082.
      View in: PubMed
    6. Gumaste PV, Fleming NH, Silva I, Shapiro RL, Berman RS, Zhong J, Osman I, Stein JA. Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines? J Natl Compr Canc Netw. 2014 Dec; 12(12):1706-12. PMID: 25505211.
      View in: PubMed
    7. Fleming NH, Zhong J, da Silva IP, Vega-Saenz de Miera E, Brady B, Han SW, Hanniford D, Wang J, Shapiro RL, Hernando E, Osman I. Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients. Cancer. 2015 Jan 01; 121(1):51-9. PMID: 25155861.
      View in: PubMed
    8. Gold HL, Wengrod J, de Miera EV, Wang D, Fleming N, Sikkema L, Kirchhoff T, Hochman T, Goldberg JD, Osman I, Gardner LB. PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition. Mol Cancer Res. 2014 Mar; 12(3):433-9. PMID: 24336958.
      View in: PubMed
    9. Qian M, Ma MW, Fleming NH, Lackaye DJ, Hernando E, Osman I, Shao Y. Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis. Melanoma Res. 2013 Dec; 23(6):461-7. PMID: 24165034.
      View in: PubMed
    10. Fleming NH, Tian J, Vega-Saenz de Miera E, Gold H, Darvishian F, Pavlick AC, Berman RS, Shapiro RL, Polsky D, Osman I. Impact of age on the management of primary melanoma patients. Oncology. 2013; 85(3):173-81. PMID: 24008821.
      View in: PubMed
    Nathaniel's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Similar People
    People who share similar concepts with this person.
    _
    Same Department